Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma PatientsAbdullah S. Al Saleh, Shaji Kumar, Harsh Parmar et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 33
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosisAlissa Visram, Shaji Kumar, Martha Q. Lacy et al.|Blood Cancer Journal|2021Cited by 29
Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100Alissa Visram, Shaji Kumar, S. Vincent Rajkumar et al.|Leukemia|2022Cited by 29
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman‐Mazur, Shaji Kumar, Alissa Visram et al.|Blood Advances|2022Cited by 28
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agentsIuliana Vaxman, Morie A. Gertz, Alissa Visram et al.|Bone Marrow Transplantation|2020Cited by 21